Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 7;10(2):e200128.
doi: 10.1212/NXG.0000000000200128. eCollection 2024 Apr.

Novel SGCE Mutation in a Patient With Myoclonus-Dystonia: A Case Report

Affiliations

Novel SGCE Mutation in a Patient With Myoclonus-Dystonia: A Case Report

Eva Klinman et al. Neurol Genet. .

Abstract

Objectives: Characterize the presentation, workup, and management of SGCE myoclonus-dystonia, a rare genetic condition, in a patient with atypical presenting symptoms and no family history of movement abnormalities.

Methods: A woman with myoclonus and dystonia was identified based on clinical history and physical examination. Workup was conducted to determine the cause of her symptoms, including whole-exome sequencing. Myoclonus-dystonia is associated with more than 100 distinct mutations in MYC/DYT-SGCE that account for only half of the total myoclonus-dystonia patients. As such, this case required intensive genetic analyses rather than screening only for a small subset of well-characterized mutations.

Results: Childhood onset myoclonus and worsening dystonia with age were identified in a young woman. She underwent screening for common causes of twitching movements, followed by whole-exome sequencing which identified a de novo novel variant in the SGCE gene, resulting in a diagnosis of SGCE myoclonus-dystonia.

Discussion: Myoclonus-dystonia should be considered in patients with symptoms of head and upper extremity myoclonus early in life, especially with co-occurring dystonia, even in the absence of a family history of similar symptoms. Diagnosis of this condition should take place using sequencing, as new mutations continue to be discovered.

PubMed Disclaimer

Conflict of interest statement

The authors report no relevant disclosures. Go to Neurology.org/NG for full disclosures.

Figures

Figure
Figure. Pedigree of Patient With SGCE Myoclonus-Dystonia
The proband (III-3) developed startle myoclonus and dystonia of the legs and hands at approximately age 10 years, which worsened over time. No other individuals in the family were known to have similar symptoms, and neither parent was a carrier of the identified mutation. The proband's father (II-1) has an unknown family history due to adoption. Unrelated conditions in the family include epilepsy in the maternal grandmother (I-2) and sarcoid in the father (II-1).

References

    1. Menozzi E, Balint B, Latorre A, Valente EM, Rothwell JC, Bhatia KP. Twenty years on: myoclonus‐dystonia and ε‐sarcoglycan—neurodevelopment, channel, and signaling dysfunction. Mov Disord. 2019;34(11):1588-1601. doi: 10.1002/mds.27822 - DOI - PubMed
    1. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001;29(1):66-69. doi: 10.1038/ng709 - DOI - PubMed
    1. Van der Veen S, Zutt R, Klein C, et al. Nomenclature of genetically determined myoclonus syndromes: recommendations of the international Parkinson and movement disorder society task force. Mov Disord. 2019;34(11):1602-1613. doi: 10.1002/mds.27828 - DOI - PMC - PubMed
    1. Raymond D, Saunders-Pullman R, Ozelius L. SGCE Myoclonus-Dystonia. GeneReviews®; 1993. - PubMed
    1. Roze E, Lang AE, Vidailhet M. Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment. Curr Opin Neurol. 2018;31(4):484-490. doi: 10.1097/WCO.0000000000000577 - DOI - PubMed